FDA Approves Wegovy to Reduce Heart Attack and Stroke Risk
“The blockbuster weight loss drug Wegovy is now approved to reduce heart
disease risk, drugmaker Novo Nordisk said Friday… The change comes
after, in a late-stage clinical trial of more than 17,000 adults, Novo
Nordisk found that Wegovy cut the risk of cardiovascular events — such
as heart attack and stroke — by 20% compared […]
The post FDA Approves Wegovy to Reduce Heart Attack and Stroke Risk
appeared first on Human Progress.
https://humanprogress.org/fda-approves-wegovy-to-reduce-heart-attack-and-stroke-risk/View article
View summary
